In a patient with no comorbidities who was switched from subcutaneous antiplatelet therapy plus aspirin to apixaban 5 mg twice daily, and now has rectal/anal pain only on straining or during urination without abdominal distension, how should this pain be managed?

Management of Rectal/Anal Pain in Patient on Apixaban

This rectal/anal pain occurring only with straining or urination most likely represents an anal fissure or internal hemorrhoids, and you should perform a careful anorectal examination to identify the source before considering any modification to anticoagulation. 1

Diagnostic Approach

The key clinical features here point away from anticoagulation-related bleeding complications:

• Pain pattern is characteristic of anorectal pathology: Pain specifically with straining or defecation is the cardinal symptom of anal fissure 1
• Absence of systemic symptoms: No abdominal distension or generalized pain argues against serious bleeding complications like rectus sheath hematoma, which would present with acute abdominal pain and potentially hemodynamic instability 2, 3, 4
• Localized symptoms only: The pain is confined to the anal/rectal area during specific activities

Essential Physical Examination Elements

Perform a focused anorectal examination looking for:

• Anal fissure: Best visualized by everting the anal canal with opposing traction using your thumbs - look for the characteristic posterior midline tear 1
• Thrombosed external hemorrhoids: Would present as a palpable, painful perianal lump 1
• Internal hemorrhoids: Require anoscopy with adequate lighting to visualize 1
• Perianal abscess or fistula: Rule out with external examination 1

Critical point: Anal pain is generally NOT associated with uncomplicated hemorrhoids unless thrombosis has occurred, so pain mandates closer investigation 1

Anticoagulation Considerations

Continue Apixaban Unless Active Bleeding Identified

The apixaban 5 mg twice daily dosing is appropriate based on the FDA label 5, and there is no indication to stop or reduce it based on pain alone. However:

• If you identify an anal fissure or hemorrhoids WITHOUT active bleeding: Continue apixaban and treat the underlying anorectal condition conservatively (fiber supplementation, stool softeners, sitz baths)

• If there is evidence of bleeding (even minor rectal bleeding): Remember that hemorrhoids alone do not cause positive fecal occult blood, and the colon requires adequate evaluation 1. While apixaban increases gastrointestinal bleeding risk compared to aspirin (0.89% vs 0.40% per 100 patient-years) 6, most bleeding events are non-emergencies characterized by hemoglobin drops ≥2 g/dL rather than life-threatening hemorrhage

Risk Factors to Assess

Specifically ask about and document:

• NSAID use: This dramatically increases bleeding risk (HR 10.25) and should be avoided 6
• Cancer history: Increases bleeding risk (HR 2.87) 6
• Age consideration: Each 5-year increase in age raises bleeding risk (HR 1.47) 6

Treatment Algorithm

1. Perform anorectal examination → Identify specific pathology (fissure, hemorrhoids, abscess)

2. If anal fissure identified:

   • Conservative management: High-fiber diet, stool softeners, topical nitroglycerin or calcium channel blockers
   • Continue apixaban unless active bleeding present
   • Pain should improve within 2-4 weeks with conservative measures

3. If internal hemorrhoids (grades 1-3):

   • Conservative management initially
   • Continue apixaban
   • Consider office-based procedures (rubber band ligation, sclerotherapy) only after careful risk-benefit discussion

4. If thrombosed external hemorrhoid:

   • If seen within 48-72 hours: Consider excision (requires temporary apixaban hold per FDA guidance - discontinue 24-48 hours before procedure depending on bleeding risk) 5
   • If beyond 72 hours: Conservative management with analgesics and sitz baths

5. If no clear anorectal pathology found:

   • Consider urological evaluation given pain association with urination
   • May represent prostatitis or other genitourinary pathology

Common Pitfalls to Avoid

• Do not attribute all anorectal symptoms to anticoagulation: The pain pattern here is mechanical (straining-related), not spontaneous bleeding
• Do not empirically reduce or stop apixaban: The 5 mg twice-daily dose is correct unless patient meets specific dose-reduction criteria (age ≥80 years, weight ≤60 kg, creatinine ≥1.5 mg/dL - needs at least 2 of 3) 5
• Do not restart aspirin: Adding aspirin to apixaban significantly increases major bleeding (RR 3.15) without reducing ischemic events in primary prevention 7
• Do not ignore concomitant anal fissures: Up to 20% of patients with hemorrhoids have coexisting anal fissures 1

The patient's switch from subcutaneous antiplatelet plus aspirin to apixaban was appropriate, and the current symptoms warrant local anorectal evaluation and treatment rather than systemic anticoagulation modification.